Elsevier logo

Publisher: Elsevier

Related content
Volume 3, Number 1, February 2003

< previous issue | all issues | next issue >

Editorial board
pp. i-i(1)

Contents
pp. iii-iii(1)

Treatment options for status epilepticus
pp. 6-11(6)
Author: Lowenstein D.H.

GABAA receptor function and pharmacology in epilepsy and status epilepticus
pp. 12-18(7)
Authors: Jones-Davis D.M.; Macdonald R.L.

Recent developments from genetic mouse models of seizures
pp. 19-26(8)
Authors: Upton N.; Stratton S.

Pharmacology of traumatic brain injury
pp. 27-32(6)
Authors: Royo N.; Shimizu S.; Schouten J.; Stover J.; McIntosh T.

GDNF and somatostatin in sensory neurones
pp. 41-45(5)
Author: Malcangio M.

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?
pp. 62-67(6)
Authors: Malan T.P.; Ibrahim M.M.; Lai J.; Vanderah T.W.; Makriyannis A.; Porreca F.

Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis
pp. 78-84(7)
Authors: John C.D.; Buckingham J.C.

The MCH receptor family: feeding brain disorders?
pp. 85-89(5)
Author: Forray C.

Trace amine receptors as targets for novel therapeutics: legend, myth and fact
pp. 90-97(8)
Authors: Branchek T.A.; Blackburn T.P.

Active drug metabolites in drug development
pp. 98-100(3)
Author: Gad S.C.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page